ROS are generated in various metabolic pathways, including the mitochondrial electron transport chain, activation of NADPH oxidases (NOX), etc. Model studies have established that in breast cancer, ROS are formed both in tumor cells and in the cancer stroma and are capable of inducing cell migration. This evidence concerns the gene FMO5 and breast carcinoma.